Literature DB >> 28332876

EVALUATION AND MANAGEMENT OF ADRENAL INSUFFICIENCY IN CRITICALLY ILL PATIENTS: DISEASE STATE REVIEW.

Amir H Hamrahian, Maria Fleseriu.   

Abstract

OBJECTIVE: The definition of normal adrenal function in critically ill patients remains controversial, despite a large body of literature. We review the clinical presentation, diagnosis, and treatment of adrenal insufficiency in critically ill patients and discuss the authors' personal approach to patient management.
METHODS: Extensive literature review, guidelines from professional societies, and personal experience.
RESULTS: A decrease in cortisol breakdown rather than an increase in cortisol production has been suggested as the main contributor to elevated cortisol levels in critically ill patients. The concept of relative adrenal insufficiency has multiple pathophysiologic flaws and is not supported by current evidence. Patients with septic shock who are pressor dependent or refractory to fluid resuscitation may receive a short course of hydrocortisone regardless of their serum cortisol levels or their response to a cosyntropin stimulation test (CST). Patients without septic shock who are suspected to have adrenal insufficiency should have their random cortisol levels measured. In patients with low and near-normal cortisol-binding proteins, a serum cortisol of <10 or 15 μg/dL, respectively, may trigger need for glucocorticoid treatment. Assays of free cortisol levels offer an advantage over total cortisol levels in patients with low binding proteins. Most critically ill patients have a normal random free cortisol level of >1.8 μg/dL, although further studies are needed to define a normal range in critically ill patients based on both severity and duration of illness. A CST may be used to further evaluate adrenal function in patients without septic shock who have borderline random serum or free cortisol levels.
CONCLUSION: Evaluation of adrenal function in critically ill patients is complex. Recent findings of decreased cortisol breakdown in critically ill patients as the main contributor to elevated cortisol levels calls for better-designed studies to explore the optimal evaluation and treatment of adrenal insufficiency in critically ill patients. ABBREVIATIONS: ACTH = adrenocorticotropic hormone; AI = adrenal insufficiency; CBG = corticosteroid-binding globulin; CORTICUS = Corticosteroid Therapy of Septic Shock; CRH = corticotropin-releasing hormone; CST = cosyntropin stimulation test; GC = glucocorticoid; GR = glucocorticoid receptor; HPA = hypothalamic-pituitary-adrenal; IL = interleukin; RAI = relative adrenal insufficiency.

Entities:  

Mesh:

Year:  2017        PMID: 28332876     DOI: 10.4158/EP161720.RA

Source DB:  PubMed          Journal:  Endocr Pract        ISSN: 1530-891X            Impact factor:   3.443


  6 in total

1.  The hollow adrenal gland sign: a newly described enhancing pattern of the adrenal gland on dual-phase contrast-enhanced CT for predicting the prognosis of patients with septic shock.

Authors:  Yang Peng; Qiuxia Xie; Huanjun Wang; Zhi Lin; Fan Zhang; Xuhui Zhou; Jian Guan
Journal:  Eur Radiol       Date:  2019-04-01       Impact factor: 5.315

Review 2.  Glucocorticoids and resilience.

Authors:  Joanna L Spencer-Segal; Huda Akil
Journal:  Horm Behav       Date:  2018-11-24       Impact factor: 3.587

3.  Plasma Free Cortisol in States of Normal and Altered Binding Globulins: Implications for Adrenal Insufficiency Diagnosis.

Authors:  Laura E Dichtel; Melanie Schorr; Claudia Loures de Assis; Elizabeth M Rao; Jessica K Sims; Kathleen E Corey; Puja Kohli; Patrick M Sluss; Michael J McPhaul; Karen K Miller
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

4.  The Impact of Covid-19 Viral Infection on the Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Ali S Alzahrani; Noha Mukhtar; Abeer Aljomaiah; Hadeel Aljamei; Abdulmohsen Bakhsh; Nada Alsudani; Tarek Elsayed; Nahlah Alrashidi; Roqayh Fadel; Eman Alqahtani; Hussein Raef; Muhammad Imran Butt; Othman Sulaiman
Journal:  Endocr Pract       Date:  2020-12-15       Impact factor: 3.443

5.  Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients.

Authors:  Graciela Cárdenas; María Chávez-Canales; Ana María Espinosa; Antonio Jordán-Ríos; Daniel Anica Malagon; Manlio Fabio Márquez Murillo; Laura Victoria Torres Araujo; Ricardo Leopoldo Barajas Campos; Rosa María Wong-Chew; Luis Esteban Ramirez González; Karent Ibet Cresencio; Enrique García Velázquez; Mariana Rodriguez de la Cerda; Yoana Leyva; Joselin Hernández-Ruiz; María Luisa Hernández-Medel; Mireya León-Hernández; Karen Medina Quero; Anahí Sánchez Monciváis; Sergio Hernández Díaz; Ignacia Rosalia Zeron Martínez; Adriana Martínez-Cuazitl; Iván Noé Martínez Salazar; Eduardo Beltrán Sarmiento; Aldo Figueroa Peña; Patricia Saraí Hernández; Rafel Ignacio Aguilar Reynoso; Daniela Murillo Reyes; Luis Rodrigo Del Río Ambriz; Rogelio Antonio Alfaro Bonilla; Jocelyn Cruz; Leonor Huerta; Nora Alma Fierro; Marisela Hernández; Mayra Pérez-Tapia; Gabriela Meneses; Erick Espíndola-Arriaga; Gabriela Rosas; Alberto Chinney; Sergio Rosales Mendoza; Juan Alberto Hernández-Aceves; Jaquelynne Cervantes-Torres; Anai Fuentes Rodríguez; Roxana Olguin Alor; Sandra Ortega Francisco; Evelyn Alvarez Salazar; Hugo Besedovsky; Marta C Romano; Raúl J Bobes; Helgi Jung; Gloria Soldevila; Juan López-Alvarenga; Gladis Fragoso; Juan Pedro Laclette; Edda Sciutto
Journal:  Trials       Date:  2022-02-14       Impact factor: 2.279

6.  EVALUATION OF THE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN A PAEDIATRIC INTENSIVE CARE UNIT.

Authors:  M Demiral; E Kiral; E C Dinleyici; E Simsek
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Oct-Dec       Impact factor: 0.877

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.